{"&cites=16502718046409290145&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa065044","authors":["RJ Motzer","RJ Motzer TE Hutson","RJ Motzer TE Hutson P Tomczak…"],"year":2007,"numCitations":6133,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa065044","citationUrl":"http://scholar.google.com/scholar?cites=12674526305022444340&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:NAM1m4X25K8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12674526305022444340&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596876833733},{"title":"Sorafenib in advanced clear-cell renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa060655","authors":["B Escudier","B Escudier T Eisen","B Escudier T Eisen WM Stadler…"],"year":2007,"numCitations":5345,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa060655","citationUrl":"http://scholar.google.com/scholar?cites=4193023401754303534&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Lhx3fJGcMDoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4193023401754303534&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673607619047","authors":["B Escudier","B Escudier A Pluzanska","B Escudier A Pluzanska P Koralewski","B Escudier A Pluzanska P Koralewski A Ravaud…"],"year":2007,"numCitations":2570,"pdf":"https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/download/52342/39075","citationUrl":"http://scholar.google.com/scholar?cites=5427817888518646484&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:1Cqqnpx7U0sJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5427817888518646484&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3646307/","authors":["RJ Motzer","RJ Motzer TE Hutson","RJ Motzer TE Hutson P Tomczak…"],"year":2009,"numCitations":2287,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3646307/","citationUrl":"http://scholar.google.com/scholar?cites=9930987091739607833&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:GQMhsCT00YkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9930987091739607833&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673611616139","authors":["BI Rini","BI Rini B Escudier","BI Rini B Escudier P Tomczak","BI Rini B Escudier P Tomczak A Kaprin","BI Rini B Escudier P Tomczak A Kaprin C Szczylik…"],"year":2011,"numCitations":1695,"citationUrl":"http://scholar.google.com/scholar?cites=3547505814206124423&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:h5FjFr5FOzEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3547505814206124423&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0140673609602294","authors":["BI Rini","BI Rini SC Campbell","BI Rini SC Campbell B Escudier"],"year":2009,"numCitations":1387,"pdf":"https://oncologypro.esmo.org/content/download/233726/3944876/file/2019-ESMO-ESO-Course-Valencia-Renal-Cancer-Christoph-Oing.pdf","citationUrl":"http://scholar.google.com/scholar?cites=807962691249077211&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:23urc8l1NgsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=807962691249077211&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","url":"https://www.onlinejacc.org/content/53/24/2231.abstract","authors":["ETH Yeh","ETH Yeh CL Bickford"],"year":2009,"numCitations":1071,"pdf":"https://www.sciencedirect.com/science/article/pii/S073510970901064X","citationUrl":"http://scholar.google.com/scholar?cites=18232091917699968513&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Ae7GWgBnBf0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18232091917699968513&hl=en&as_sdt=2005&sciodt=0,5","publication":"onlinejacc.org"},{"title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","url":"https://www.sciencedirect.com/science/article/pii/S0140673607618650","authors":["TF Chu","TF Chu MA Rupnick","TF Chu MA Rupnick R Kerkela","TF Chu MA Rupnick R Kerkela SM Dallabrida…"],"year":2007,"numCitations":1008,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2643085/","citationUrl":"http://scholar.google.com/scholar?cites=8218067125806684648&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:6NkFfoJwDHIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8218067125806684648&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","url":"https://www.nature.com/articles/6603813/","authors":["T Kamba","T Kamba DM McDonald"],"year":2007,"numCitations":895,"pdf":"https://www.nature.com/articles/6603813/","citationUrl":"http://scholar.google.com/scholar?cites=7877130468290417470&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:PlPbE20wUW0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7877130468290417470&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients","url":"https://clincancerres.aacrjournals.org/content/15/6/2148.short","authors":["JS Ko","JS Ko AH Zea","JS Ko AH Zea BI Rini","JS Ko AH Zea BI Rini JL Ireland","JS Ko AH Zea BI Rini JL Ireland P Elson…"],"year":2009,"numCitations":792,"pdf":"https://clincancerres.aacrjournals.org/content/clincanres/15/6/2148.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14164454896869690621&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:_cz1pK5AksQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14164454896869690621&hl=en&as_sdt=2005&sciodt=0,5","publication":"AACR"}]}